RheinBio announced that the company is planning a change in control, issue shares, and pay cash to purchase assets and raise supporting capital. Due to uncertainties on related matters, trading of the company's shares began to be suspended when the market opened on December 10, 2025, and is expected to be suspended for no more than 10 consecutive trading days. As of the disclosure date of this announcement, the company and all parties concerned are actively promoting all aspects of this transaction, and the relevant parties are negotiating, verifying and confirming the transaction plan. In order to protect investors' interests and avoid abnormal fluctuations in the trading price of the company's securities, trading of the company's shares will continue to be suspended in accordance with the relevant regulations of the Shenzhen Stock Exchange.

RheinBio announced that the company is planning a change in control, issue shares, and pay cash to purchase assets and raise supporting capital. Due to uncertainties on related matters, trading of the company's shares began to be suspended when the market opened on December 10, 2025, and is expected to be suspended for no more than 10 consecutive trading days. As of the disclosure date of this announcement, the company and all parties concerned are actively promoting all aspects of this transaction, and the relevant parties are negotiating, verifying and confirming the transaction plan. In order to protect investors' interests and avoid abnormal fluctuations in the trading price of the company's securities, trading of the company's shares will continue to be suspended in accordance with the relevant regulations of the Shenzhen Stock Exchange.